Dr. Satinath Mukhopadhyay Endocrinologist in Kolkata

Dr. Satinath Mukhopadhyay

Endocrinologist, Kolkata

MBBS, MD, DM

  • 36 Years Experience
  • 2 Hospitals

About

Dr. Satinath Mukhopadhyay is an Endocrinologist at Institute of Post Graduate Medical Education & Research and Life Line Home in Kolkata, West Bengal.He has over 30 years of Experience in the field of endocrinology.

He has completed his MBBS at Calcutta Medical College, Kolkata and then did his MD from University College of Medicine and after that, he pursued DM from Institute of Postgraduate Medical Education & Research (IPGMER), Kolkata, West Bengal.

He is also a Member of European Society of Endocrinology, European Association for the study of Diabetes (EASD), European Neuroendocrine Association (ENEA), Endocrine Society of India, Indian Society for Bone and Mineral Research (ISBMR) and Association of Physicians of India (API).

Specialities

  • Endocrinology

  • Diabetology

Conditions

  • Cushing's Syndrome

  • Diabetes Type 1

  • Diabetes Type 2

  • Hyperprolactinemia

  • Hyperthyroidism
  • More

Education

MBBS, 1982, Calcutta Medical College, Kolkata, India

MD, 1988, University College of Medicine, India

DM, 1997, Institute of Post Graduate Medical Education and Research (IPGME&R), Kolkata, India

Practice Information

IPGMER SSKM Hospital, Kolkata

IPGMER SSKM Hospital, Kolkata

244, A J C Bose Road, Kolkata, West Bengal - 700020

Sethi Diagnostic & Medicare, Kolkata

Sethi Diagnostic & Medicare, Kolkata

Behala Tram Depot, 1D, Diamond Harbour Road, Kolkata, West Bengal - 700034

Achievements & Contributions

  • A phase II clinical trial to study the safety and efficacy of 2mg and 4mg of ZYH1 compared to Pioglitazone 45mg in dyslipidemia with type 2 diabetes mellitus. Zydus Cadila. 2006-08.
  • A phase III multi-centric, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of ZYH1 compared to Pioglitazone 45mg in dyslipidemia with type 2 diabetes mellitus. Zydus Cadila. 2009-10.
  • A multi-centric, prospective, randomised, double blind study to evaluate the safety and efficacy of 2mg and 4mg of ZYH1 compared to placebo in hypertriglyceridemia with type II diabetes not controlled with Atorvastatin therapy. Zydus Cadila. 2009-10.
  • An open label, multicentric, interventional Phase III trial to evaluate the safety and efficacy of recombinant PTH (teriparatide) in post-menopausal osteoporosis. Zydus Cadila. 2010-11.
  • A phase IIa randomised, double-blind, placebo-controlled study to evaluate the effects of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and overall safety in the treatment of Osteoporosis in postmenopausal women previously treated with Alendronate. Merck Co & Inc. 2009-11.
  • A non-interventional, multicentric study to compare hepatic fat and relevant metabolic parameters in overweight/obese prediabetic/diabetic subjects, with healthy subjects in different geographical regions in India. Torrent Pharma. 2011-12.
  • A multi-centric, prospective, randomised, double blind, parallel group, active controlled study to evaluate the safety and efficacy of ZYH7 compared to Fenofibrate in patients with dyslipidemia. Zydus Cadila. 2011-12.
  • A phase III randomised, placebo–controlled clinical trial to assess the safety and efficacy of Odanacatib (MK-0822) to reduce the risk of fracture in osteoporotic postmenopausal women treated with Vitamin D and Calcium. Merck Co & Inc. 2009-12.
  • Inositol phospholipid signalling in apoptotic death of insulin producing beta cells leading to diabetes. Department of Biochemistry, Ballygunge Science College, University of Calcutta. [Ongoing]
  • Molecular characterisation of initial events during apoptosis of pancreatic beta cells and isolated rat islets upon treatment with cytokines (TNF- alpha etc.) and streptozotocin, which create diabetic animal models. Department of Biochemistry, Ballygunge Science College, University of Calcutta. [Ongoing]
  • Gene Expression Study involving Adipose tissue and skeletal muscle of insulin resistant subjects with Type 2 Diabetes. Department of Molecular Endocrinology of IICB, Kolkata. [Ongoing]
  • Genetic profile of monogenic childhood obesity. Department of Molecular Endocrinology of IICB, Kolkata. [Ongoing]
  • Role of free fatty acids in regulation of Fetuin A and NFkB gene expression in animal models of Type 2 Diabetes. Department of Zoology, Viswabharati University. [Ongoing]
  • Mitochondrial dysfunction in diabetic neuropathy. Bangur Institute of Neurology and IICB, Kolkata. [Ongoing]
  • Differential expression of mitochondrial CPT isoforms may explain intramyocellular lipid accumulation, oxidative stress and reduced glucose uptake in palmitate-treated C2C12 and L6 muscle cell lines. CSIR. [Ongoing]
  • Early postnatal androgenisation of female Sprague-Dawley rats leads to polycystic changes in the ovary by dysregulation of WNT4/β-Catenin pathway and collagen metabolism. CSIR. [Ongoing]
  • Early postnatal androgenisation of female Sprague-Dawley rats leads to metaplastic changes in the endomtrium. CSIR. [Ongoing]
  • A multi-centric, prospective, randomised, open label phase IV clinical study to evaluate the safety and efficacy of Saroglitazar (ZYH1) as compared to fenofibrate in patients with dyslipidemia. Zydus Cadila. [Ongoing]
  • Effect of vitamin-D supplementation on changes in systemic inflammatory markers, insulin resistance, 1-hour plasma glucose levels and progression to overt diabetes in patients of pre-diabetes with vitamin-D deficiency: A randomised controlled trial. WBDST. [Ongoing]
  • Best Speaker Award. Diabetes Association of India. National Diabetes Congress.1993
  • Comment on: Jeffery et al. Age before Stage: Insulin Resistance Rises Before the Onset of Puberty: A 9-Yr Longitudinal Study (Early Bird 26). Anubhav Thukral, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury. Diabetes Care. 2012; Vol. 35: 536-541.
  • Response to: Thyroid Dysfunction and Fibrin Network Structure: A Mechanism for Increased Thrombotic Risk in Hyperthyroid Individuals. Anubhav Thukral, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury. JCEM. 2012.
  • The missing false negatives: Response to Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. Anubhav Thukral, Rana Bhattacharya, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury. JCEM. 2012; Vol. 97: 3467-3475.
  • Widespread vitamin D deficiency among Indian health care professionals. Maria Beloyartseva, Ambrish Mithal, Parjeet Kaur, Sanjay Kalra, Manash P Baruah, Satinath Mukhopadhyay, Ganapathy Bantwal & Tushar R Bandgar. Arch Osteoporos. Dec 2012; Vol. 7, (1-2): 187-192.
  • Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Durba Pal, Suman Dasgupta, Rakesh Kundu, Sudipta Maitra, Gobardhan Das, Satinath Mukhopadhyay, Sukanta Ray, Subeer S Majumdar & Samir Bhattacharya. Nature Medicine. Aug 2012; Vol. 18, No. 8: 1279-1285.
  • Marcus-Gunn Jaw Winking Syndrome and Gustatory Sweating in Long Standing Poorly Controlled Diabetes: A Case Report. Deep Dutta, Indira Maisnam, Sujoy Ghosh, Pradip Mukhopadhyay, Satinath Mukhopadhyay, Subhankar Chowdhury. International Journal of Clinical Medicine. 2012; Vol. 3: 40-42.
  • Myxedema Coma: A New Look into an Old Crisis. Vivek Mathew, Raiz Ahmad Misgar, Sujoy Ghosh, Pradip Mukhopadhyay, Pradip Roychowdhury, Kaushik Pandit, Satinath Mukhopadhyay, Subhankar Chowdhury. Journal of Thyroid Research. 2011; 7.
  • Mitochondrial bioenergetics is not impaired in nonobese subjects with type 2 diabetes mellitus. Mrittika Chattopadhyay, Ishita Guha Thakurta, Prajna Behera, Kumar Rajeev Ranjan, Manoj Khanna, Satinath Mukhopadhyay, Sasanka Chakrabarti. Metabolism.
  • NF-kB mediated lipid induced Fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance. Suman Dasgupta, Sushmita Bhattacharya, Anindita Biswas, Subeer S. Majumder, Satinath Mukhopadhyay, Sukanta Ray, Samir Bhattacharya. Biochem J. 2010; Vol. 429: 451-462.
  • Tachykinin family genes and their receptors are differentially expressed in hypothyroid ovary and pituitary. Pamela Ghosh, Samir Kumar Saha, Sabarna Bhattacharya, Samir Bhattacharya, Satinath Mukhopadhyay, Sib Sankar Roy. Cellular Physiology and Biochemistry. 2007; Vol.20: 357-368.
  • Early treatment with low fixed dose (5mCi) Radioiodine Therapy is Effective in Indian Subjects with Graves’ Disease. Debmalya Sanyal, Pradip Mukhopadhyay, Kaushik Pandit,  Localisation and Thyroid Hormone Influenced Expression of Collagen II in Ovarian Tissue. Samir K Saha, Pamela Ghosh, Debanjali Mitra, Satinath Mukhopadhyay, Samir Bhattacharya and Sib S Roy. Cellular Physiology and Biochemistry. 2007; Vol.19: 67-76.
  • Autoimmune thyroid disease and pregnancy. outcome - a prospective observational study. A Mukhopadhyay, S Pati, S Mukhopadhyay, N Das, P Mukhopadhyay, B Saumandal. Thyroid Research & Practice. May-Aug 2007; Vol. 4, No. 2: 48-52.
  • Idiopathic hypoparathyroidism and systemic sclerosis: An association likely missed. Deep Dutta, Ram Narayan Das, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Panhypopituitarism with empty sella - a sequel of pituitary hyperplasia due to chronic primary. Deep Dutta, Indira Maisnam, Sujoy Ghosh, Pradip Mukhopadhyay, Satinath  Refractory rickets due to Fanconi's Syndrome secondary to Wilson's disease. Chitra Selvan, Anubhav Thukral, Partha P Chakraborthy, Rana Bhattacharya, Ajitesh Roy, Soumik Goswani, Dayanidhi Meher, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Hypophosphatemic rickets: A case of recurrent pathological fractures. Arjun Baidya, Subhankar Chowdhury, Satinath Mukhopadhyay, Sujoy Ghosh. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata. Arjun Baidya, Subhankar Chowdhury, Satinath Mukhopadhyay, Sujoy Ghosh. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Pancreatic carcinoma in fibrocalcific pancreatic diabetes: An eastern India perspective. Partha Pratim Chakraborty, Deep Dutta, Kaushik Biswas, Triranjan Sanyal, Sujoy Ghosh, Satinath Mukhopadhyay, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Tetany due to hypoparathyroidism as the initial manifestation of autoimmune polyendocrine syndrome. Deep Dutta, Indira Maisnam, Sujoy Ghosh, Ranen Dasgupta, Satinath Mukhopadhyay, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol 16, Issue 8.
  • Can a faulty injection technique lead to a localized insulin allergy? Trinanjan Sanyal, Sujoy Ghosh, Subhankar Chowdhury, Satinath Mukherjee. Indian Journal of Endocrinology and Metabolism. 2013; Vol 17, Issue 7.
  • Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset. Debmalaya Sanyal, Sujoy Ghosh, Pradip Mukherjee, Satinath Mukherjee, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Evaluation of diabetic polyneuropathy in Type 2 diabetes mellitus by nerve conduction study. Avijit Mondal, Sangita Sen, Debarati Chanda, Sunanda Kundu, Mitali Chatterjee, Satinath Mukherjee. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • De morseir syndrome presenting as ambiguous genitalia. Anubhav Thukral, S Chitra, Partho P Chakraborty, Ajitesh Roy, Soumik Goswami, Rana Bhattacharjee, Deep Dutta, Indira Maisnam, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury. Indian Journal of Endocrinology and Metabolism. 2012; Vol. 16, Issue 8.
  • Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test:Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Sandeep Chaudhary, Anubhav Thukral, Manoj Kataria, Sujoy Ghosh, Satinath Mukherjee, Subhankar Chowdhury. Diabetes Care. 2013; Vol. 36: 195-201.
  • FGF16 promotes invasive behaviour of SKOV-3 ovarian cancer cells through activation of MAPK signalling pathway. Moitri Basu, Satinath Mukhopadhyay, Uttara Chatterjee, Sib Sankar Roy. The Journal of Biological Chemistry. Nov 2013.
  • Shivaprasad K, Kumar M, Dutta D, Sinha B, Mondal SA, Maisnam I, Mukhopadhyay S, Chowdhury S. Increased Soluble TNF Receptor-1 and Glutathione Peroxidase may Predict Carotid Intima Media Thickness in Females with Cushing's Syndrome.Endocr Pract. 2014 Nov 4:1-22. [Epub ahead of print].  Impact factor 2.9.
  • Nupur Basu, Deep Dutta1, Indira Maisnam1, Swadhapriya Basu, Sujoy Ghosh1, Subhankar Chowdhury1, Satinath Mukhopadhyay. Percutaneous ethanol ablation in managingpredominantly cystic thyroid nodules: An eastern India perspective1. Indian Journal of Endocrinology and Metabolism / Sep-Oct 2014 / Vol 18 | Issue 5.
  • Dutta D, Selvan C, Kumar M, Datta S, Das RN, Ghosh S, Mukhopadhyay S, Chowdhury S.Needle aspirate PTH in diagnosis of primary hyperparathyroidismdue to intrathyroidal parathyroid cyst.Endocrinol Diabetes Metab Case Rep. 2013;2013:130019. doi: 10.1530/EDM-13-0019. Epub 2013 Jul 1.
  • Maisnam I, Dutta D, Mukhopadhyay S, Chowdhury S. Lean mass is the strongest predictor of bone mineral content in type-2 diabetes and normal individuals: an eastern India perspective.J Diabetes Metab Disord. 2014 Sep 2;13 (1):90. doi: 10.1186/s40200-014-0090-5. eCollection 2014.
  • Mukhopadhyay S, Mondal SA, Kumar M, Dutta D. Pro-inflammatory and anti-inflammatory attributes of fetuin-A: a novel hepatokine: modulating cardiovascular and glycemic outcomes in metabolic syndrome.Endocr Pract. 2014 Nov 4:1-18. [Epub ahead of print]. Impact factor 2.9.
  • RH Jani, V Pai, P Jha, G Jariwala, S Mukhopadhyay, A Bhansali, S Joshi, A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared with Placebo in Type 2 Diabetes Mellitus Patients Having Hypertriglyceridemia Not Controlled with Atorvastatin Therapy (PRESS VI) Diabetes technology & therapeutics. 2014; 16 (2), 63-71. Impact Factor: 2.205.
  • Member, American Endocrine Society.
  • Member, Endocrine Society of India.
  • Member, European Society of Endocrinology.
  • Member, European Association for the Study of Diabetes (EASD).
  • Member, European Neuroendocrine Association (ENEA).
  • Member, Indian Society for Bone and Mineral Research (ISBMR).
  • Member, Indian Society for Pediatric and Adolescent Endocrinology (ISPAE).
  • Member, Association of Physicians of India (API).
  • Member, Research Society for the Study of Diabetes in India (RSSDI).
  • Member, Cardiological Society of India (CSI).
-->